Skip to main content
. 2018 Apr 30;11:2419–2427. doi: 10.2147/OTT.S156505

Table 1.

Characteristics of researches included in the meta-analysis

Study Country (ethnicity) Source of control Methods miRNA SNP Number of subjects Case
Control
TT/GG CT/CG CC/CC TT/GG CT/CG CC/CC
Yin et al21 Chinese (Asian) H TaqMan PCR 196a2 rs11614913 1,183 149 298 128 178 297 133
Shang et al22 Chinese (Asian) P PCR-RFLP 196a2 rs11614913 116 7 17 8 48 26 10
Yin et al23 Chinese (Asian) H TaqMan PCR 196a2 rs11614913 568 67 141 50 97 150 63
Vinci et al16 Italian (Caucasian) H PCR-HRMA 196a2 rs11614913 230 12 54 35 10 61 58
Hong et al24 Korean (Asian) P TaqMan PCR 196a2 rs11614913 834 96 224 86 134 198 96
Kim et al25 Korean (Asian) H Fluorescence 196a2 rs11614913 1,294 162 305 187 185 300 155
Tian et al26 Chinese (Asian) P PCR-RFLP 196a2 rs11614913 2,093 293 512 253 307 519 209
Yin et al21 Chinese (Asian) H TaqMan PCR 146a rs2910164 1,183 97 280 198 127 313 168
Yin et al23 Chinese (Asian) H TaqMan PCR 146a rs2910164 568 45 134 79 63 160 87
Jia et al27 Chinese (Asian) H PCR-RFLP 146a rs2910164 800 64 182 154 76 200 124
Jeon et al28 Korean (Asian) P PCR-RFLP 146a rs2910164 2,187 223 500 368 244 540 312
Vinci et al16 Italian (Caucasian) H PCR-HRMA 146a rs2910164 230 44 48 9 73 45 11
Tian et al26 Chinese (Asian) P PCR-RFLP 146a rs2910164 2,093 360 510 188 364 502 169

Abbreviations: miRNA, microRNA; SNP, single-nucleotide polymorphism; P, population; H, hospital; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; HRMA, high resolution melting analysis.